157 related articles for article (PubMed ID: 37835547)
21. Multiple Negative Fecal Immunochemical Tests Reduce Risk of Advanced Neoplasia in a Colonoscopy Surveillance Program.
Wassie MM; Young GP; Winter JM; Cock C; Bampton P; Rahman M; Heddle R; Fraser R; Meng R; Symonds EL
Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2389-2398.e2. PubMed ID: 36610499
[TBL] [Abstract][Full Text] [Related]
22. COVID-19 Impact on Diagnosis and Staging of Colorectal Cancer: A Single Tertiary Canadian Oncology Center Experience.
Castonguay M; El Sayed R; Richard C; Vachon MF; Nassabein R; Charpentier D; Tehfé M
Curr Oncol; 2022 May; 29(5):3282-3290. PubMed ID: 35621658
[TBL] [Abstract][Full Text] [Related]
23. Interval cancers in a population-based screening program for colorectal cancer with gender-specific cut-off levels for fecal immunochemical test.
Ribbing Wilén H; Saraste D; Blom J
J Med Screen; 2022 Sep; 29(3):156-165. PubMed ID: 35257615
[TBL] [Abstract][Full Text] [Related]
24. Colorectal neoplasia prevalence in a predominantly Hispanic community: Results from a colorectal cancer screening program in Texas.
Willauer AN; Zuckerman MJ; Alomari A; Alvarado LA; Salaiz R; Casner N; Dwivedi AK; Shokar NK
Am J Med Sci; 2022 Oct; 364(4):394-403. PubMed ID: 35398033
[TBL] [Abstract][Full Text] [Related]
25. Risk prediction for advanced neoplasia using longitudinal adherence measures to fecal immunochemical test-based colorectal cancer screening programs.
de Jonge L; Riggi E; van Duuren LA; Toes-Zoutendijk E; Campari C; Sassatelli R; Arrigoni A; Orione L; Lansdorp-Vogelaar I; Senore C
Prev Med; 2023 May; 170():107488. PubMed ID: 36931473
[TBL] [Abstract][Full Text] [Related]
26. Impact of a colorectal cancer screening program implantation on delays and prognosis of non-screening detected colorectal cancer.
Cubiella J; Lorenzo M; Baiocchi F; Tejido C; Conde A; Sande-Meijide M; Castro M
World J Gastroenterol; 2021 Oct; 27(39):6689-6700. PubMed ID: 34754161
[TBL] [Abstract][Full Text] [Related]
27. Cost Effectiveness of Mailed Outreach Programs for Colorectal Cancer Screening: Analysis of a Pragmatic, Randomized Trial.
Kapinos KA; Halm EA; Murphy CC; Santini NO; Loewen AC; Skinner CS; Singal AG
Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2383-2392.e4. PubMed ID: 35144024
[TBL] [Abstract][Full Text] [Related]
28. Colonoscopy later than 270 days in a fecal immunochemical test-based population screening program is associated with higher prevalence of colorectal cancer.
Zorzi M; Hassan C; Capodaglio G; Baracco M; Antonelli G; Bovo E; Rugge M
Endoscopy; 2020 Oct; 52(10):871-876. PubMed ID: 32356282
[TBL] [Abstract][Full Text] [Related]
29. Impact of SARS-CoV-2 Pandemic on Colorectal Cancer Screening Delay: Effect on Stage Shift and Increased Mortality.
Ricciardiello L; Ferrari C; Cameletti M; Gaianill F; Buttitta F; Bazzoli F; Luigi de'Angelis G; Malesci A; Laghi L
Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1410-1417.e9. PubMed ID: 32898707
[TBL] [Abstract][Full Text] [Related]
30. Association between time to colonoscopy after positive fecal testing and colorectal cancer outcomes in Alberta, Canada.
Brenner DR; Carbonell C; Xu L; Nemecek N; Yang H
J Med Screen; 2024 Mar; ():9691413241239023. PubMed ID: 38486492
[TBL] [Abstract][Full Text] [Related]
31. Delayed Colorectal Cancer Diagnosis during the COVID-19 Pandemic in Alberta: A Framework for Analyzing Barriers to Diagnosis and Generating Evidence to Support Health System Changes Aimed at Reducing Time to Diagnosis.
Walker E; Fu Y; Sadowski DC; Stewart D; Tang P; Kaposhi B; Chappell H; Robson P; Veldhuyzen van Zanten S
Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501687
[TBL] [Abstract][Full Text] [Related]
32. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
[TBL] [Abstract][Full Text] [Related]
33. Gender-specific cut-off levels in colorectal cancer screening with fecal immunochemical test: A population-based study of colonoscopy findings and costs.
Ribbing Wilén H; Saraste D; Blom J
J Med Screen; 2021 Dec; 28(4):439-447. PubMed ID: 34106777
[TBL] [Abstract][Full Text] [Related]
34. Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme: individual-level data analysis.
Toes-Zoutendijk E; de Jonge L; van Iersel CA; Spaander MCW; van Vuuren AJ; van Kemenade F; Ramakers CR; Dekker E; Nagetaal ID; van Leerdam ME; Lansdorp-Vogelaar I
Gut; 2023 Jul; 72(7):1319-1325. PubMed ID: 37076272
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of adenomatous polyposis in a fecal immunochemical test-based colorectal cancer screening program and risk of advanced neoplasia during follow-up.
Carballal S; Sánchez A; Moreira L; Cuellar-Monterrubio JE; Bernuy J; Daca M; Ortiz O; Ocaña T; Rivero-Sánchez L; Jung G; Serradesanferm A; Pozo A; Grau J; Torá I; Zaffalon D; Castells A; Pellisé M; Balaguer F;
Endoscopy; 2022 Jul; 54(7):688-697. PubMed ID: 34607378
[TBL] [Abstract][Full Text] [Related]
36. Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels.
Ribbing Wilén H; Blom J; Höijer J; Hultcrantz R
J Gastroenterol Hepatol; 2019 Jan; 34(1):103-112. PubMed ID: 29968937
[TBL] [Abstract][Full Text] [Related]
37. Adenoma Detection Rate and Colorectal Cancer Risk in Fecal Immunochemical Test Screening Programs : An Observational Cohort Study.
Zorzi M; Antonelli G; Barbiellini Amidei C; Battagello J; Germanà B; Valiante F; Benvenuti S; Tringali A; Bortoluzzi F; Cervellin E; Giacomin D; Meggiato T; Rosa-Rizzotto E; Fregonese D; Dinca M; Baldassarre G; Scalon P; Pantalena M; Milan L; Bulighin G; Di Piramo D; Azzurro M; Gabbrielli A; Repici A; Rex DK; Rugge M; Hassan C; ; Giacomin A; Buda A; Costa D; Checchin D; Marin R; Patarnello E; Ceriani A; Guido E; Bertomoro P; Merlini N; Murer F; Ntakirutimana E; Benazzato L; Bellocchi MCC
Ann Intern Med; 2023 Mar; 176(3):303-310. PubMed ID: 36802754
[TBL] [Abstract][Full Text] [Related]
38. Impact of colorectal cancer screening participation in remote northern Canada: A retrospective cohort study.
Smith HA; Scarffe AD; Brunet N; Champion C; Kandola K; Tessier A; Boushey R; Kuziemsky C
World J Gastroenterol; 2020 Dec; 26(48):7652-7663. PubMed ID: 33505142
[TBL] [Abstract][Full Text] [Related]
39. [Diagnostic performance of quantitative fecal immunochemical test in detection of advanced colorectal neoplasia].
Lu M; Chen HD; Liu CC; Zhang YH; Wei LP; Lyu ZY; Ren JS; Shi JF; Zou SM; Li N; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2104-2111. PubMed ID: 33378824
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]